Latest Breaking News On - Company or small pharma - Page 6 : comparemela.com

Small Pharma Announces Positive Six-month Data from Phase

Approximately two-thirds of trial patients with Major Depressive Disorder achieving remission following SPL026 treatment sustained remission to six-months.

City ofUnited kingdomJaber mohamedRalph metznerGeorge tzirasCarol routledgeBehavioral sciencesUniversity of california san franciscoCompany or small pharmaRegulatory agencyWeill institute for neurosciencesPsychedelics divisionSmall pharma incCompany phase iiaMajor depressive disorderMontgomery asberg depression rating scale

Small Pharma Announces Further Positive Data from SPL026

-Patients’ self-reported depression and wellbeing scores corroborate MADRS efficacy data-Statistically significant improvement in anxiety symptoms offers.

City ofUnited kingdomJaber mohamedEric ribnerGeorge tzirasCarol routledgeCompany or small pharmaSmall pharma incCompany phase iiaLancet global healthRegulatory agencyMajor depressive disorderMontgomery asberg depression rating scaleBeck depression inventoryState trait anxiety inventoryWarwick edinburgh mental wellbeing scale

Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomEric ribnerlifesci advisorsemailJaber mohamedmhp communicationsemailDavid erritzoeCarol routledgeJerry rosenbaumImperial college london onRegulatory agencyCompany or small pharmaProfessor of psychiatry at harvard medical schoolSmall pharma incSmall pharma inc george tzirasVenture exchangeRegulation services providerWall street

Small Pharma Announces Update on Intellectual Property Portfolio with Two New Patents Approved for Issue

01.02.2023 - New United States patents will provide further support for the Company’s proprietary position in a key jurisdiction United States grants will bring the Company’s total to 16 granted patents and over 90 applications pending LONDON, Feb. 01, 2023 . Seite 1

United statesCity ofUnited kingdomTrademark officeCompany or small pharmaSmall pharma incUnited states patentIssue notificationGood manufacturing practice

Small Pharma Inc : Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder

First placebo-controlled efficacy study completed to date exploring a short-duration psychedelic for depression demonstrates rapid and durable response Primary endpoint met with a statistically significant

City ofUnited kingdomJaber mohamedEric ribnerGeorge tzirasCarol routledgeCompany or small pharmaSmall pharma incCompany phase iiaCompany phaseCompany phase iibRegulatory agencyMajor depressive disorderMontgomery asberg depression ratingChief medicalScientific officer